Description: Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. It operates through the EU (the United Kingdom and Germany) and the United States geographic regions. Through the United Kingdom segment, it provides protein separation and MS capabilities for identification and analysis of post-translational modification of proteins in protein phosphorylation, image analysis and bioinformatics. Through the Germany segment, it provides protein profiling technologies, such as Tandem Mass Tags (TMT), which offers quantitation of proteins for the discovery of biomarkers. It has research agreements with various institutions in the United States.
Home Page: www.proteomics.com
PRM Technical Analysis
Coveham House
Cobham,
KT11 3EP
United Kingdom
Phone:
44 20 7043 2116
Officers
| Name | Title |
|---|---|
| Dr. Mariola Sohngen | CEO & Exec. Director |
| Dr. Ian H. Pike | Chief Scientific Officer & Exec. Director |
| Mr. Richard Paul Dennis | Chief Commercial Officer & Exec. Director |
| Mr. Abdelghani Omari | CFO & Director |
| Mr. Glenn Barney | VP of Sales & Marketing |
| Victoria Birse | Company Sec. |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.8901 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 27 |